Skip to content
USPeptideRxLearnApply for an account

Operator Q&A

Do I need a DEA number to order compounded medications?

USPeptideRx EditorialLast reviewed:

A DEA registration is a controlled-substance authority, so it is engaged when the preparation is a controlled substance and not otherwise. Across the states whose rules we have read in full, we found no provision making your DEA number the credential a supplier must verify or retain before supplying you; the identifier the rules name is the licence or permit issued by the state where the product will be received. Two of those states additionally require a state controlled-substance registration for each physical location the moment scheduled stock sits on site.

What is the short answer?

A DEA registration is a controlled-substance authority. It comes into an order when the preparation is a controlled substance, and across the rules we have read it is not what a supplier has to verify before supplying you.

That second half is the part that surprises people, so it is worth stating precisely. Across the states whose rules we read in full, we found no provision making the DEA number the credential a supplier must check or retain before supplying a prescriber. The identifier the rules name is the licence or permit issued by the state where the product will be received.

What do suppliers actually have to verify, then?

Your state credential — and in at least one state the duty is written directly onto the shipper.

Arizona requires a nonresident permittee to "maintain a copy of the current permit or license of each person in Arizona that buys, receives, or disposes of" the drug, producible within two business days. That is a licence copy, not a DEA number. Louisiana binds distributors to sell legend drugs "only to a person who is authorized, by law or regulation, to procure or possess" them — a general authorisation duty with no DEA element.

The office-use records states require point the same way. Illinois's mandatory office-use record identifies the ordering practitioner by name, address and phone, alongside the product details, lot number and beyond-use date, retained five years. Texas's office-use audit trail must be queryable by practitioner, facility, pharmacy, ingredient, lot number and dosage form. Neither carries a DEA field.

Was there ever a rule requiring a supplier to check it?

One, and it was deleted — which makes it the most useful piece of history on this page.

Colorado formerly imposed an office-use duty on suppliers to verify each practitioner's licence and DEA registration. That paragraph, along with several neighbouring ones covering quantity caps, labelling and distribution records, was deleted effective 30 November 2021. It was the only express verify-the-DEA duty we found in any of the states we read.

One correction worth carrying, because the shorthand misleads: the rule itself was not repealed. It was re-populated, and now reads as an express prohibition on nonresident distribution of compounded products into Colorado. "The Colorado office-use rule was repealed" is wrong in a way that matters if you are relying on it.

When does the DEA number come into the order at all?

On the prescription, where the preparation is a controlled substance.

Illinois's statutory definition of a prescription is the cleanest statement of the line we found. Its enumerated elements include "DEA registration number where required, for controlled substances," and it adds that "DEA registration numbers shall not be required on inpatient drug orders." The number is a conditional element, conditioned on the substance.

Two Florida points sit alongside this. Florida has no separate state controlled-substance registration — the DEA number is built into the statutory definition of "practitioner." And a Florida practitioner registered as a dispensing practitioner "may not dispense a controlled substance listed in Schedule II or Schedule III," subject to narrow exceptions. Administering such a preparation in the office is a different act from sending the patient home with a vial, and Florida treats them differently.

Does your state add its own registration on top?

Several have removed theirs, two require one per location, and one is unresolved.

StateSeparate state controlled-substance registration for a practitioner
TexasNo — § 481.061 is now captioned "Federal registration required"; the state-registration subsections were repealed effective 1 September 2016. Content still circulates telling Texas clinics to obtain a state number
FloridaNo — the DEA number is built into the statutory definition of "practitioner"
ArizonaNone found — a Title 32 licence plus DEA registration, with mandatory prescription-monitoring-programme registration for every DEA-registered practitioner
CaliforniaNone found in our reading — enrolment in the state monitoring programme is mandatory on receipt of the DEA registration
LouisianaYes, and per location: a practitioner's licence "shall be valid in any location in Louisiana; however, the procurement and possession of controlled substances shall require a separate CDS license for each such location where controlled substances are possessed"
New JerseyYes, per registered location. The office exemption applies only where no controlled substances are "administered, delivered, or otherwise dispensed, and no such substances are contained in such office"
North CarolinaUnresolved — see below

The Louisiana and New Jersey rows are the operationally sharp ones. A three-location practice needs three Louisiana registrations, and New Jersey's office exemption collapses the moment scheduled stock is on the premises.

Why is North Carolina unresolved?

Because the rule waiving practitioner registration points at a statute that no longer exists, while the agency behaves as though registration is required.

North Carolina's rule waives registration for individual practitioners except as noted in a statutory subsection that was repealed in 2019, leaving the exception a dead reference. Meanwhile the state's Drug Control Unit maintains a clinic registration category with its own fee, an application form, and an unannounced inspection during the registration period, and states publicly that using controlled substance schedules requires registration with both state and federal agencies.

We are not going to resolve that here. If you hold scheduled stock in North Carolina, treat a clean "no registration needed" as unsupported and ask the Drug Control Unit directly.

What should you take from this when opening an account?

That the file will be waiting on a state credential, not on your DEA number.

If an account is held up, the document in question is almost always the licence or permit for the receiving site — which is also why the site on the application has to be the site the product is going to. Authority to prescribe travels with the person; authority to hold attaches to the address — and which person or entity may hold at all is a separate question, answered at who may lawfully order compounded medications for a clinic.

What a supplier verifies in full is at prescriber credentialing, and the enumerated document list is at what documents a compounding pharmacy needs from your clinic. Whether the transaction you are being credentialed for is permitted where you practise is a separate question, answered with rule text at office-use compounding by state.

To have your licences, your sites and your intended pathway checked before you commit to a supplier, you can apply for an account.

What this page does not establish

  • This page does not tell you whether you need a DEA registration in order to practise. We did not retrieve the federal registration rules — 21 C.F.R. Part 1301 and the Controlled Substances Act registration provisions — and nothing here describes them. What this page addresses is the narrower question of what role the number plays when ordering.
  • Whether any given compounded preparation is a controlled substance is not answered here. Our substance-status research covers federal compounding eligibility and records no controlled-substance scheduling for any substance in it. Testosterone is the only scheduled drug identified anywhere in our research, as Schedule III in Arizona’s rules. Do not read this page as saying a preparation is uncontrolled.
  • The statement that no rule we read makes the NPI or the DEA number the supply-gating credential is a scoped negative. It covers the states we have read in full from primary sources — Georgia, North Carolina, Ohio, Louisiana, New Jersey, Illinois, Texas, Florida, California, New York, Arizona and Colorado — and only the rules within them that we read. It is not a national finding and does not mean no such requirement exists elsewhere, nor that a supplier will not ask for the number for its own reasons.
  • State controlled-substance registration status for practitioners was not checked for Georgia, Ohio, Illinois or Colorado.
  • New York practitioner controlled-substance recordkeeping under 10 NYCRR Part 80 was not retrieved and no claim is made about it.
  • North Carolina is genuinely unresolved and is presented as such below rather than as a clean answer in either direction.
  • Educational information, not legal advice. Verify with your own counsel and your state board.
  • Nothing here describes any drug’s safety or effectiveness.

Sources

Primary sources, fetched directly from the issuing body. No secondary summaries.

  1. [1]225 ILCS 85 — Illinois Pharmacy Practice Act (definition of “Prescription”, element 7)
  2. [2]68 Ill. Adm. Code 1330.640 — office-use records (contents and five-year retention)
  3. [3]Tex. Health & Safety Code § 481.061 — “Federal registration required” (Justia, 2025 edition)
  4. [4]Texas State Board of Pharmacy — rules compilation (22 TAC §§ 291.131, 291.133 office-use audit trail; § 291.34 controlled-substance distribution cap)
  5. [5]Fla. Stat. § 465.0276 — dispensing practitioners (Florida Senate)
  6. [6]LAC Title 46:LIII § 2705 — Louisiana controlled dangerous substances licence (Division of Administration file)
  7. [7]N.J.A.C. 13:45H — New Jersey controlled dangerous substances registration
  8. [8]A.A.C. Title 4, Ch. 23 — Arizona Board of Pharmacy rules (R4-23-607 nonresident permittees; R4-23-501 CSPMP registration)
  9. [9]Cal. Health & Safety Code § 11165.1 — prescription drug monitoring programme enrolment (California Legislative Information)
  10. [10]Colorado State Board of Pharmacy rules, 3 CCR 719-1 (Rule 21; the deleted office-use verification duty at former 21.00.20(g))